Indacaterol Market
This report contains market size and forecasts of Indacaterol in global, including the following ... Read More
This report contains market size and forecasts of Afatinib in Global, including the following market information:
Global Afatinib Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Afatinib market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
30mg Tables Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Afatinib include Boehringer Ingelheim, Hengrui Medicine and Beacon Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Afatinib companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Afatinib Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Afatinib Market Segment Percentages, by Type, 2021 (%)
30mg Tables
40mg Tables
50mg Tables
25mg Tables
20mg Tables
Other
Global Afatinib Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Afatinib Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Drug Center
Other
Global Afatinib Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Afatinib Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Afatinib revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Afatinib revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Boehringer Ingelheim
Hengrui Medicine
Beacon Pharma
This report contains market size and forecasts of Indacaterol in global, including the following ... Read More
This report contains market size and forecasts of Siltuximab in global, including the following m ... Read More
This report contains market size and forecasts of Naldemedine in global, including the following ... Read More
This report contains market size and forecasts of Daratumumab in global, including the following ... Read More